Cytocom, Inc. was founded in 2014

The company is incorporated in Delaware

The company completed its merger July 28, 2021

The company’s fiscal years ends December 31st

The company’s common stock is listed on the NASDAQ Market under the symbol “CYTO”

The transfer Agent and registrar for the common stock of Cytocom stock is:

Continental Stock Transfer & Trust Company
1 State Street Plaza
30th Floor
New York, NY 10004
212-509-4000
www.continentalstock.com

Continental Stock Transfer & Trust Company
1 State Street Plaza
30th Floor
New York, NY 10004
212-509-4000
www.continentalstock.com

To change the address on your shareholder account you must send both your old and new addresses to our transfer agent,

Continental Stock Transfer & Trust Company
1 State Street Plaza
30th Floor
New York, NY 10004
212-509-4000

To transfer stock or replace a lost stock certificate, contact our transfer agent, Continental Stock Transfer & Trust Company

Meaden & Moore

1375 East Ninth Street, Suite 1800
Cleveland, Ohio 44114-1790

866-752-4651
https://www.meadenmoore.com/

To find out more about Cytocom visit their webpage at www.cytocom.com

Cytocom’s press release archive can be viewed under the “Press Release” section of the “Investors” page and financial reports are available under the “SEC Filings” section of the “Investors” page located at our website: www.cytocom.com.

Cytocom’s SEC Filings can be found on www.sec.gov and are also available under the “SEC Filings” section of the “Investors” page located at our website www.cytocom.com.